SCHEMBL5141804

SCHEMBL5141804

O=C(Nc1ccc(Cl)c(Cl)c1)Nc1ccc(-c2cc(CN3CCOCC3)n3ncnc(Nc4ccccc4)c23)cc1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACVRL1 P37023 5/20 0.45
EGFR P00533 4/20 0.43
KDR P35968 3/20 0.42
BRAF P15056 2/20 0.42
MERTK Q12866 1/20 0.42
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
MTOR P42345 3/20 0.41
PIK3CA P42336 1/20 0.41
PIK3CG P48736 1/20 0.41
RET P07949 1/20 0.41
BCR P11274 1/20 0.41
FGFR1 P11362 1/20 0.41
FLT3 P36888 1/20 0.41
FRK P42685 1/20 0.41
MAPK9 P45984 1/20 0.41
RPS6KA3 P51812 1/20 0.41
PRKCD Q05655 1/20 0.41
DDR1 Q08345 1/20 0.41
MAP4K2 Q12851 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL60189 0.88 ACVRL1 (0.59) ACVRL1KDRMERTKHTR2AHTR2C
SCHEMBL5142452 0.87 ACVRL1 (0.49) ACVRL1EGFRKDRBRAFMERTK
SCHEMBL90888 0.82 ACVRL1 (0.57) ACVRL1KDRMERTKHTR2AHTR2C
SCHEMBL59260 0.82 ACVRL1 (0.57) ACVRL1KDRMERTKRETBCR
SCHEMBL58934 0.81 ACVRL1 (0.56) ACVRL1EGFRKDRBRAFMERTK
SCHEMBL58935 0.79 ACVRL1 (0.57) ACVRL1KDRMERTKRETBCR
SCHEMBL879087 0.79 ACVRL1 (0.57) ACVRL1KDRMERTKMTORRET
SCHEMBL5141239 0.79 KDR (0.47) ACVRL1KDRMERTKRETBCR
SCHEMBL59539 0.79 ACVRL1 (0.57) ACVRL1KDRMERTKRETBCR
SCHEMBL58828 0.79 ACVRL1 (0.47) ACVRL1KDRMERTKHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957485-A2 SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS Bayer Healthcare, LLC (US) 2008-08-20 EP claimed
WO-2007064931-A2 SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS BAYER HEALTHCARE LLC (US) 2007-06-07 WO claimed